Prime Minister Boris Johnson announced that DIOSynVax, a biotech spinout of the University of Cambridge, will receive $42 million (about £32 million...
Fourteen-day quarantine measures imposed on incoming travellers returning to England in summer 2020 helped prevent the spread of the SARS-CoV-2 virus...
The Omicron variant of SARS-CoV-2 may be significantly better than previous variants at evading vaccine-induced antibodies, according to new research...
When a team of doctors, scientists and engineers at Addenbrooke’s Hospital and the University of Cambridge placed an air filtration machine in COVID-...